High-Resolution Mapping of Drug Conjugated Peptides in an ADC Digest
Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordspeptides, adc, peptide, mapping, drug, conjugated, advancebio, cytotoxic, maps, gradient, capacity, hydrophobic, peak, mau, trastuzumab, time, resolution, column, min, flow, values, digest, mab, rsd, mean, across, rate, postrun, conjugation, reproducibility, more, alkylated, shows, heterogeneous, biosimilars, denaturing, dividing, biologics, under, excellent, ones, criterion, thermostatted, thermostat, were, glycosylation, obtained, high, degasser, lysine
Similar PDF
Analysis of Tryptic Digests of a Monoclonal Antibody and an Antibody-Drug Conjugate with the Agilent 1290 Infinity II LC
2016|Agilent Technologies|Applications
Analysis of Tryptic Digests of a Monoclonal Antibody and an Antibody-Drug Conjugate with the Agilent 1290 Infinity II LC Application Note Biopharmaceuticals and Biosimilars Authors Abstract Gerd Vanhoenacker, Mieke Steenbeke, An Agilent 1290 Infinity II LC in combination with an…
Key words
kadcyla, kadcylamau, mauherceptin, herceptintryptic, trypticdigests, digestsmin, minpeptide, peptideantibody, antibodycapacity, capacitygradient, gradientdelay, delaydrug, drugmab, mabmixing, mixingpeak
Agilent Biocolumns - Critical Quality Attributes - Application Compendium
2018|Agilent Technologies|Guides
Agilent Biocolumns Critical Quality Attributes Application Compendium Contents Introduction 05 1 Titer determination 07 1.1 1.2 1.3 1.4 1.5 Background Getting Started How to Guide - Affinity Chromatography for Titer Determination Featured Application Notes Cell Clone Selection Using the Agilent…
Key words
return, returnsection, sectioncontents, contentsmau, mauadvancebio, advancebiopeptide, peptidemin, minglycan, glycanprotein, proteinbiosimilar, biosimilaramino, aminoinnovator, innovatormapping, mappingcolumn, columnagilent
Characterizing Antibody-Drug Conjugates and Assigning Drug Conjugation Sites
2017|Agilent Technologies|Applications
Characterizing Antibody-Drug Conjugates and Assigning Drug Conjugation Sites Using the Agilent 1290 Infinity II 2D-LC Solution Combined with the Agilent 6530 Quadrupole Time-of-Flight LC/MS System Application Note Biopharmaceuticals Authors Abstract Koen Sandra, Gerd Vanhoenacker, Antibody-drug conjugates (ADCs) are a promising…
Key words
conjugated, conjugatedantibody, antibodyrplc, rplcmmae, mmaeconjugation, conjugationbrentuximab, brentuximabdrug, drugpeptides, peptidesherceptin, herceptinadcetris, adcetrisintrachain, intrachainscdk, scdkkadcyla, kadcylainterchain, interchainpayload
High-Performance Biopharma Analysis - Application compendium
2021|Agilent Technologies|Guides
Agilent InfinityLab Bio LC Solutions High-Performance Biopharma Analysis Application compendium 2 Overcome Analytical Challenges in Biopharma The growing complexity of biopharma analysis calls for innovation that delivers excellence across the biopharmaceutical workflow. The Agilent InfinityLab Bio LC Solutions comprise a…
Key words
retention, retentionbio, biomin, mingradient, gradienttime, timenistmab, nistmabresponse, responsemau, maupeptide, peptidemapping, mappingagilent, agilentcharge, chargemab, mabrsd, rsdantibody